Author: GlobeNewswire

DALLAS, Oct. 26, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (“Taysha”), a patient-centric, pivotal-stage gene therapy company…

Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia as the company continues to…

GAINESVILLE, Fla. and CAMBRIDGE, Mass. and LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC” or…

Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today…

REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and…

Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from assignment of…

ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing…

Data support the Company’s lead investigational product candidate sparsentanSAN DIEGO, Oct. 26, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ:…

FOSTER CITY, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…

SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…